NSC |
Compound |
Enrichment |
Correlation |
NSC 671118 |
Null |
0.00336064452966825 |
0.0029396532 |
NSC 628572 |
Null |
0.0033606445296683 |
0.27154115 |
NSC 657321 |
1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- |
0.0033606445296683 |
0.042929987 |
NSC 106557 |
5.alpha.,25D-Spirostan-3.beta.-ol glycoside |
0.00337662564965909 |
-0.014443974 |
NSC 18300 |
Null |
0.00337662564965909 |
0.22936021 |
NSC 635306 |
Null |
0.00337662564965909 |
0.072428791 |
NSC 642311 |
Null |
0.00337662564965909 |
0.216275 |
NSC 703784 |
L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride |
0.00337662564965909 |
-0.2321112 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.00337662564965909 |
0.22990914 |
NSC 750873 |
2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol |
0.00337662564965909 |
0.3444668 |